Evidence map›Paper›PMID 22848344›Full record

Trial reportPloS one2012

Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.

Anthony Bejjani, Joseph O'Neill, John A Kim, Andrew J Frew, Victor W Yee, Ronald Ly, Christina Kitchen, Noriko Salamon, James T McCracken, Arthur W Toga and 2 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. A Developmental Neuroimmune Cascade Model of Autism Spectrum Disorder.International journal of molecular sciences · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.International journal of molecular sciences · 2022
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Anthony BejjaniAhmanson-Lovelace Brain Mapping Center, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America.
Joseph O'Neill
John A Kim
Andrew J Frew
Victor W Yee
Ronald Ly
Christina Kitchen
Noriko Salamon
James T McCracken
Arthur W Toga
Jeffry R Alger
Jennifer G Levitt
University of California, Los Angeles · USBrain Mapping Foundation · US

Funding

Understanding Neuropsychiatic Disorders Among UnderserveP01MH063357 · NIMH · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI STRICKLAND, TONY L · 2002 to 2004
$2.2M
Neuroimaging and Symptom Domains in AutismR01NS046018 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEVITT, JENNIFER G · 2003 to 2007
$2.1M
BIOLOGICAL BASIS OF SOCIAL COMMUNICATION DISORDERSK08MH001385 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEVITT, JENNIFER G · 1997 to 2001
$300k
NIMH NIH HHS K08-MH01385NIMH NIH HHS P01 MH063357NIMH NIH HHS P01 MH63357NINDS NIH HHS R01 NS046018NINDS NIH HHS R01NS46018-01
6 · The paper itself

Abstract

Recent research in autism spectrum disorder (ASD) has aroused interest in anterior cingulate cortex and in the neurometabolite glutamate. We report two studies of pregenual anterior cingulate cortex (pACC) in pediatric ASD. First, we acquired in vivo single-voxel proton magnetic resonance spectroscopy ((1)H MRS) in 8 children with ASD and 10 typically developing controls who were well matched for age, but with fewer males and higher IQ. In the ASD group in midline pACC, we found mean 17.7% elevation of glutamate + glutamine (Glx) (p<0.05) and 21.2% (p<0.001) decrement in creatine + phosphocreatine (Cr). We then performed a larger (26 subjects with ASD, 16 controls) follow-up study in samples now matched for age, gender, and IQ using proton magnetic resonance spectroscopic imaging ((1)H MRSI). Higher spatial resolution enabled bilateral pACC acquisition. Significant effects were restricted to right pACC where Glx (9.5%, p<0.05), Cr (6.7%, p<0.05), and N-acetyl-aspartate + N-acetyl-aspartyl-glutamate (10.2%, p<0.01) in the ASD sample were elevated above control. These two independent studies suggest hyperglutamatergia and other neurometabolic abnormalities in pACC in ASD, with possible right-lateralization. The hyperglutamatergic state may reflect an imbalance of excitation over inhibition in the brain as proposed in recent neurodevelopmental models of ASD.

Indexed as

Magnetic Resonance ImagingMagnetic Resonance SpectroscopyAdolescentBrain ChemistryCerebral CortexChildChild Development Disorders, PervasiveFemaleGlutamic AcidGlutamineHumansMaleModels, NeurologicalPhosphocreatinePilot ProjectsRadiographyGlutamic AcidGlutaminePhosphocreatine

Identifiers

PMID22848344
PMCPMC3407186
OpenAlexW2072983646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.